COV — CLEO Diagnostics Balance Sheet
0.000.00%
Last trade - 00:00- AU$56.54m
- AU$49.23m
- AU$0.60m
- 55
- 12
- 54
- 37
Annual balance sheet for CLEO Diagnostics, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|
| Period Length: | — | — | — |
| Source: | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final |
| Cash | |||
| Cash and Equivalents | |||
| Cash and Short Term Investments | 0.043 | 0.24 | 9.37 |
| Net Total Accounts Receivable | |||
| Net Total Receivables | 0.001 | 0.032 | 0.057 |
| Prepaid Expenses | |||
| Total Current Assets | 0.044 | 0.58 | 9.44 |
| Gross Property, Plant And Equipment | |||
| Accumulated Depreciation | |||
| Net Property, Plant And Equipment | — | 0.038 | 0.032 |
| Net Intangible Assets | |||
| Total Assets | 0.244 | 1.08 | 9.88 |
| Accounts Payable | |||
| Accrued Expenses | |||
| Notes Payable / Short Term Debt | |||
| Total Current Liabilities | 0.286 | 2.02 | 0.486 |
| Total Long Term Debt | |||
| Total Debt | |||
| Total Liabilities | 0.286 | 2.02 | 0.486 |
| Common Stock | |||
| Retained Earnings (Accumulated Deficit) | |||
| ESOP Debt Guarantee | |||
| Other Equity | |||
| Total Equity | -0.042 | -0.943 | 9.39 |
| Total Liabilities & Shareholders' Equity | 0.244 | 1.08 | 9.88 |
| Total Common Shares Outstanding |